Pitolisant
ATC N07XX11 · 8 markets · 20 records
US 4 records · 2 strengths
GB 2 records · 2 strengths
CA 2 records · 2 strengths
CN 2 records · 2 strengths
- 18 mgtabletManufacturer: Bioprojet Pharma ×2
- 4.5 mgtabletManufacturer: Bioprojet Pharma ×2
ES 2 records · 2 strengths
TW 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 Wakix
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 OZAWADE、Wakix
| Strength / form / release | US | GB | CA | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|
| 18 mg tablet | Wakix | Manufacturer: Bioprojet Pharma ×2 | Wakix | Wakix 唯醒膜衣錠18毫克 | ||||
| 4.5 mg tablet | Wakix | Manufacturer: Bioprojet Pharma ×2 | Wakix | Wakix 唯醒膜衣錠4.5毫克 | ||||
| 17.8 mg tablet | No trade name Wakix | |||||||
| 4.45 mg tablet | No trade name Wakix | |||||||
| 20 mg tablet | Wakix | |||||||
| 5 mg tablet | Wakix | |||||||
unknown | Wakix | OZAWADE Wakix |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.